LONG-TERM SAFETY OF SODIUM OXYBATE IN PAEDIATRIC NARCOLEPSY WITH CATAPLEXY: OPEN-LABEL CONTINUATION AFTER 1 YEAR OF TREATMENT

被引：0
|
作者：
Strunc, M. J. [1 ]
Mignot, E. [2 ]
Wang, Y. G. [3 ]
Black, J. [2 ,3 ]
Chakravarthy, D. [3 ]
Parvataneni, R. [3 ]
Plazzi, G. [4 ]
机构：
[1] Childrens Hosp Kings Daughters, Ctr Pediat Sleep Med, Norfolk, VA USA
[2] Stanford Ctr Sleep Sci & Med, Stanford, CA USA
[3] Jazz Pharmaceut Inc, Palo Alto, CA USA
[4] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
来源：
SLEEP MEDICINE | 2019年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [21] Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study
    Tanaka, Yoshiya
    Curtis, Paula
    DeRose, Kathleen
    Kurrasch, Regina
    Kinoshita, Kyoko
    Tanaka, Rika
    Yamazaki, Yumi
    Roth, David A.
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 122 - 133
  • [22] Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a postauthorization, noninterventional surveillance study
    Mayer, Geert
    Plazzi, Giuseppe
    Iranzo, Alex
    Ortega-Albas, Juan
    Quinnell, Timothy
    Pesch, Hanna
    Serralheiro, Pedro
    Schlit, Anne-Francoise
    Wuiame, Didier
    Bentz, Jurgen W. G.
    SLEEP, 2018, 41 (09)
  • [23] Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
    Michael Spaeth
    Cayetano Alegre
    Serge Perrot
    Youyu Grace Wang
    Diane R Guinta
    Sarah Alvarez-Horine
    Irwin Jon Russell
    Arthritis Research & Therapy, 15
  • [24] Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia
    Spaeth, Michael
    Alegre, Cayetano
    Perrot, Serge
    Wang, Youyu Grace
    Guinta, Diane R.
    Alvarez-Horine, Sarah
    Russell, Irwin Jon
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [25] A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy
    Black, J
    Guilleminault, C
    Bogan, R
    Feldman, N
    Hagaman, M
    Hertz, G
    Iyer, V
    Kathawalla, S
    Lankford, A
    Mitler, M
    Hayduk, R
    Sahota, P
    Roth, T
    Scharf, M
    Scrima, L
    Schwartz, J
    Zammit, G
    SLEEP, 2003, 26 (01) : 31 - 35
  • [26] PROPRANOLOL - LONG-TERM TREATMENT IN NARCOLEPSY-CATAPLEXY
    MEIEREWERT, K
    MATSUBAYASHI, K
    BENTER, L
    SLEEP, 1985, 8 (02) : 95 - 104
  • [27] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [28] Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia
    Chambers, Mark S.
    Jones, Christopher Uwe
    Biel, Merrill A.
    Weber, Randal S.
    Hodge, Kenneth M.
    Chen, Y.
    Holland, John M.
    Ship, Jonathan A.
    Vitti, Robert
    Armstrong, Ingrid
    Garden, Adam S.
    Haddad, Robert
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05): : 1369 - 1376
  • [29] A 12-Week, Open-Label Study Evaluating Sodium Oxybate (SXB) in Patients with Narcolepsy
    Mamelak, Mortimer
    Swick, Todd
    Emsellem, Helene
    Montplaisir, Jacques
    Lai, Chinglin
    Black, Jed
    ANNALS OF NEUROLOGY, 2014, 76 : S131 - S132
  • [30] Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation
    Plazzi, Giuseppe
    Ruoff, Chad
    Lecendreux, Michel
    Dauvilliers, Yves
    Rosen, Carol L.
    Black, Jed
    Parvataneni, Rupa
    Guinta, Diane
    Wang, Youyu Grace
    Mignot, Emmanuel
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (07): : 483 - 494
12345